No registrations found.
ID
Source
Brief title
Health condition
intermittent claudication; peripheral arterial disease
Sponsors and support
Intervention
Outcome measures
Primary outcome
1. Number of walking stops caused by intermittent claudication;
2. Painfree walking distance;
3. Functional walking distance.
Secondary outcome
1. Walking distance;
2. Walking speed;
3. Walking time;
4. Pain-scores (VAS).
Background summary
N/A
Study objective
The Dynaport MoveMonitor can accurately assess walking periods, movement intensity and walking stops related to intermittent claudication.
Study design
N/A
Intervention
Dynport MoveMonitor measuring device.
Polikliniek Heelkunde<br>
Postbus 1350
Gert-Jan Lauret
Eindhoven 5602 ZA
The Netherlands
+31 (0)40 2398764
movepad@gmail.com
Polikliniek Heelkunde<br>
Postbus 1350
Gert-Jan Lauret
Eindhoven 5602 ZA
The Netherlands
+31 (0)40 2398764
movepad@gmail.com
Inclusion criteria
1. Patients with intermittent claudication determined with an EAI of <0.9 of <0.15 decrease after exercise;
2. Initial maximal walking distance <500m;
3. Age + gender matched control group of healty volunteers.
Exclusion criteria
Comorbidity which could influence the walking distance, for instance:
1. COPD Gold 3-4;
2. Heart failure (NYAH 2 or more);
3. Severe artrosis;
4. Amputation;
5. Walking aids.
For the control group there should be no history of peripheral arterial disease besides the above mentioned criteria.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL2816 |
| NTR-old | NTR2957 |
| Other | : |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |